Low-dose CDK4/6 inhibitors induce presentation of pathway specific MHC ligands as potential targets for cancer immunotherapy

by Angel Charles, Christopher M. Bourne, Tanya Korontsvit, Zita E. H. Aretz, Sung Soo Mun, Tao Dao, Martin G. Klatt, David A. Scheinberg
Published 2021-01-01

Solving an MHC allele–specific bias in the reported immunopeptidome

by Martin G. Klatt, Kyeara N. Mack, Yang Bai, Zita E. H. Aretz, Levy I. Nathan, Sung Soo Mun, Tao Dao, David A. Scheinberg
Published 2020-10-01